This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
King Abdullah International Medical Research Center (KAIMRC) is an international institute of biomedical and clinical research.[1] It was launched on 11 November 2006 with the approval of the Custodian of the Two Holy Mosques, King Abdullah bin Abdulaziz. The center is part of the Ministry of National Guard Health Affairs and is located in Riyadh, Saudi Arabia, with campuses in Jeddah and Al-Ahsa.[2]
| Abbreviation | KAIMRC |
|---|---|
| Formation | 11 November 2006 |
| Founder | Custodian of the Two Holy Mosques King Abdullah bin Abdul Aziz |
| Founded at | Riyadh, Saudi Arabia |
| Purpose | Biomedical and clinical research |
| Headquarters | Riyadh, Saudi Arabia |
| Location |
|
Parent organization | Ministry of National Guard Health Affairs |
| Website | kaimrc |
Achievements
editKAIMRC was awarded accreditation by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) on July 3, 2023.[3][4] The center has also started a Phase I clinical trial for a vaccine against the Middle East respiratory syndrome coronavirus (MERS-CoV) in collaboration with the Jenner Institute at the University of Oxford.[5]
References
edit- ^ https://kaimrc.ksau-hs.edu.sa/
- ^ "King Abdullah International Medical Research Center (KAIMRC)". www.ksau-hs.edu.sa.
- ^ "AAHRPP Awards Accreditation to King Abdullah International Medical Research Center (KAIMRC)". Default.
- ^ "AAHRPP Awards Accreditation to King Abdullah International Medical Research Center (KAIMRC)". kaimrc.ksau-hs.edu.sa.
- ^ Staff Writer; Gazette, Saudi. "Saudi: KAIMRC, Sanofi agree to advance clinical research and build sustainable". www.zawya.com.
External links
edit
 | This article about an organization in Saudi Arabia is a stub. You can help Wikipedia by expanding it. |
 | This article about a medical organization or association is a stub. You can help Wikipedia by expanding it. |